Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia.
Irene Della StarzaLucia Anna De NoviAlessandra SantoroDomenico SalemiWayne TamMarzia CavalliLucia MenaleRoberta SosciaValerio ApicellaCaterina IlariAntonella VitaleAnna Maria TestiGiorgio InghiramiSabina ChiarettiCaterina IlariAnna GuariniPublished in: Leukemia & lymphoma (2019)